These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 17868793

  • 1. Should beta-blockers be used to control hypertension in people with chronic kidney disease?
    Hart PD, Bakris GL.
    Semin Nephrol; 2007 Sep; 27(5):555-64. PubMed ID: 17868793
    [Abstract] [Full Text] [Related]

  • 2. Effects of beta-blockers on glucose and lipid metabolism.
    Fonseca VA.
    Curr Med Res Opin; 2010 Mar; 26(3):615-29. PubMed ID: 20067434
    [Abstract] [Full Text] [Related]

  • 3. [Arterial hypertension in patients on chronic hemodialysis].
    Zogović J, Mladenović Lj.
    Srp Arh Celok Lek; 1996 Mar; 124(9-10):246-50. PubMed ID: 9102857
    [Abstract] [Full Text] [Related]

  • 4. Beta-blockers in the treatment of hypertension: are there clinically relevant differences?
    Weir MR.
    Postgrad Med; 2009 May; 121(3):90-8. PubMed ID: 19491545
    [Abstract] [Full Text] [Related]

  • 5. [Antihypertensive therapy in renal failure].
    Mayer G.
    Acta Med Austriaca; 1995 May; 22(3):51-3. PubMed ID: 8571752
    [Abstract] [Full Text] [Related]

  • 6. Managing hypertension in chronic renal disease.
    Faubert PF, Porush JG.
    Geriatrics; 1987 Jan; 42(1):49-51, 55-8. PubMed ID: 2879773
    [Abstract] [Full Text] [Related]

  • 7. Beta-blockade in chronic dialysis patients.
    Furgeson SB, Chonchol M.
    Semin Dial; 2008 Jan; 21(1):43-8. PubMed ID: 18251957
    [Abstract] [Full Text] [Related]

  • 8. [Treatment of arterial hypertension in non-oliguric renal failure].
    Beretta-Piccoli C.
    Schweiz Med Wochenschr; 1989 Jul 22; 119(29):1016-22. PubMed ID: 2678436
    [Abstract] [Full Text] [Related]

  • 9. Renal vascular effects of calcium channel blockers in hypertension.
    Benstein JA, Dworkin LD.
    Am J Hypertens; 1990 Dec 22; 3(12 Pt 2):305S-312S. PubMed ID: 2078317
    [Abstract] [Full Text] [Related]

  • 10. Effects of long-term therapy with arotinolol on blood pressure and renal function in hypertensive patients with chronic renal failure.
    Shiigai T.
    Clin Ther; 1993 Dec 22; 15(2):330-7. PubMed ID: 7686085
    [Abstract] [Full Text] [Related]

  • 11. [beta-blockers in hypertension with renal failure].
    Guédon J, Aubert P, Lucsko M, Chaignon M.
    Nouv Presse Med; 1978 Sep 20; 7(31):2795-7. PubMed ID: 30967
    [No Abstract] [Full Text] [Related]

  • 12. Beta blockers in the management of chronic kidney disease.
    Bakris GL, Hart P, Ritz E.
    Kidney Int; 2006 Dec 20; 70(11):1905-13. PubMed ID: 17021610
    [Abstract] [Full Text] [Related]

  • 13. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW.
    Clin Ther; 2009 Mar 20; 31(3):447-62. PubMed ID: 19393838
    [Abstract] [Full Text] [Related]

  • 14. Beta blockers and renal function: a reappraisal.
    Epstein M, Oster JR.
    J Clin Hypertens; 1985 Mar 20; 1(1):85-99. PubMed ID: 2873206
    [Abstract] [Full Text] [Related]

  • 15. Do beta-blockers prolong survival in chronic heart failure? A review of the experimental and clinical evidence.
    Packer M.
    Eur Heart J; 1998 Feb 20; 19 Suppl B():B40-6. PubMed ID: 9519351
    [Abstract] [Full Text] [Related]

  • 16. Beta-blockers in hypertension.
    Ram CV.
    Am J Cardiol; 2010 Dec 15; 106(12):1819-25. PubMed ID: 21126627
    [Abstract] [Full Text] [Related]

  • 17. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
    Nephrol Dial Transplant; 2008 Feb 15; 23(2):573-9. PubMed ID: 17984104
    [Abstract] [Full Text] [Related]

  • 18. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
    Brodde OE, Philipp T.
    Dtsch Med Wochenschr; 2006 Nov 10; 131(45):2545-50. PubMed ID: 17091442
    [Abstract] [Full Text] [Related]

  • 19. One size does not fit all: the role of vasodilating beta-blockers in controlling hypertension as a means of reducing cardiovascular and stroke risk.
    Basile JN.
    Am J Med; 2010 Jul 10; 123(7 Suppl 1):S9-15. PubMed ID: 20609697
    [Abstract] [Full Text] [Related]

  • 20. Clinical trials in nephrology: success or failure.
    Garcia-Donaire JA, Segura J, Ruilope LM.
    Curr Opin Nephrol Hypertens; 2007 Mar 10; 16(2):59-63. PubMed ID: 17293678
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.